Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment
Clinical trial NCT04251741 · UNKNOWN
Trial details
- NCT number
- NCT04251741
- Sponsor
- Reade Rheumatology Research Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2024-05-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.